EurekAlert!: Scientists uncover molecular ‘switch’ that could make pancreatic cancer more treatable
Scientists at Duke-NUS Medical School have identified a molecular “switch” that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...
EurekAlert!: Phase III trial shows molecular profiling can safely reduce radiation for women with endometrial cancer and optimise treatment for patients at a higher risk patients
Phase III trial shows molecular profiling can safely reduce radiation for women with endometrial cancer and optimise treatment for patients at a higher risk patients
Please provide your email address to receive an email when new articles are posted on . Molecular profiling could spare certain patients with high-intermediate risk endometrial cancer adjuvant ...
Phys.org: How synthetic biology can transform crops, cancer therapies, and drug discovery: Q&A
Mo Khalil is the Hok Lam and Kathleen Kam Wong Professor of Bioengineering and Professor of Molecular and Cellular Biology at the Harvard John A. Paulson School of Engineering and Applied Sciences ...
How synthetic biology can transform crops, cancer therapies, and drug discovery: Q&A
ascopubs.org: Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed ...
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed ...
News Medical: Molecular profiling identifies prostate cancer patients who benefit most from chemotherapy
Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...